Literature DB >> 3405290

Extensive variation of human immunodeficiency virus type-1 in vivo.

M S Saag1, B H Hahn, J Gibbons, Y Li, E S Parks, W P Parks, G M Shaw.   

Abstract

Genotypic variation among independent isolates of human immunodeficiency virus type-1 (HIV-1) is well known, but its molecular basis and biological consequences are poorly understood. We examined the genesis of molecular variation in HIV-1 by sequential virus isolations from two chronically infected individuals and analysis of recombinant HIV-1 genomic clones. In three different virus isolates full-length HIV-1 clones were identified and found to consist, respectively, of 17, 9 and 13 distinguishable, but highly-related, viral genotypes. Thirty-five viral clones derived from two HIV-1 isolates obtained from the same individual but 16 months apart showed progressive change, yet were clearly related. Similar changes in the HIV-1 genome did not occur in vitro during virus isolation and amplification. The results indicate that HIV-1 variation in vivo is rapid, that a remarkably large number of related but distinguishable genotypic variants evolve in parallel and coexist during chronic infection, and that 'isolates' of HIV-1, unless molecularly or biologically cloned, generally consist of complex mixtures of genotypically distinguishable viruses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3405290     DOI: 10.1038/334440a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  120 in total

1.  Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys.

Authors:  D P Burns; R C Desrosiers
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

2.  Nucleotide sequence analysis of Aleutian mink disease parvovirus shows that multiple virus types are present in infected mink.

Authors:  E Gottschalck; S Alexandersen; A Cohn; L A Poulsen; M E Bloom; B Aasted
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus.

Authors:  S Alexandersen; S Carpenter
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Independent fluctuation of human immunodeficiency virus type 1 rev and gp41 quasispecies in vivo.

Authors:  L P Martins; N Chenciner; B Asjö; A Meyerhans; S Wain-Hobson
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Biological comparison of wild-type and zidovudine-resistant isolates of human immunodeficiency virus type 1 from the same subjects: susceptibility and resistance to other drugs.

Authors:  R Rooke; M A Parniak; M Tremblay; H Soudeyns; X G Li; Q Gao; X J Yao; M A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

6.  Molecular characterization of biologically diverse envelope variants of human immunodeficiency virus type 1 derived from an individual.

Authors:  R S Daniels; M H Smith; A G Fisher
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

7.  The "V3" domain is a determinant of simian immunodeficiency virus cell tropism.

Authors:  F Kirchhoff; K Mori; R C Desrosiers
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo.

Authors:  P Westervelt; D B Trowbridge; L G Epstein; B M Blumberg; Y Li; B H Hahn; G M Shaw; R W Price; L Ratner
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  Substitutions in a major histocompatibility complex class II-restricted human immunodeficiency virus type 1 gp120 epitope can affect CD4+ T-helper-cell function.

Authors:  C Lekutis; N L Letvin
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  In vitro intersubtype recombinants of human immunodeficiency virus type 1: comparison to recent and circulating in vivo recombinant forms.

Authors:  Miguel E Quiñones-Mateu; Yong Gao; Sarah C Ball; Andre J Marozsan; Awet Abraha; Eric J Arts
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.